ArticleFrontiers in immunology2025
Interpretable deep learning for gastric cancer detection: a fusion of AI architectures and explainability analysis.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Comprehensive Overview of Gastric Cancer Immunohistochemistry: Key Biomarkers, Advanced Detection Methods, and Perspectives.Medicina (Kaunas, Lithuania) · 2026Review
- Transforming Gastric Biopsy Diagnostics: Integrating Omics Technologies and Artificial Intelligence.Biomedicines · 2026Article
- An interpretable deep learning framework for intestinal metaplasia detection in gastric histopathology images.Frontiers in oncology · 2026Article
- Building novel LLM-enabled explainable ensemble transformer models combining endoscopic and CT images for discriminating the different grades of gastrointestinal cancers.Frontiers in medicine · 2026Article
- A Deep Learning-Based Approach for Explainable Microsatellite Instability Detection in Gastrointestinal Malignancies.Journal of imaging · 2025Article
- FC-YOLO: a fast inference backbone and lightweight attention mechanism-enhanced YOLO for detecting gastric adenocarcinoma in pathological image.Frontiers in oncology · 2025Article
- Atrophic gastritis of distinct etiologies: malignant potential inAnnals of gastroenterologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The rise in cases of Gastric Cancer has increased in recent times and demands accurate and timely detection to improve patients' well-being. The traditional cancer detection techniques face issues of explainability and precision posing requirement of interpretable AI based Gastric Cancer detection system. Method: This work proposes a novel deep-learning (DL) fusion approach to detect gastric cancer by combining three DL architectures, namely Visual Geometry Group (VGG16), Residual Networks-50 (RESNET50), and MobileNetV2. The fusion of DL models leverages robust feature extraction and global contextual understanding that is best suited for image data to improve the accuracy of cancer detection systems. The proposed approach then employs the Explainable Artificial Intelligence (XAI) technique, namely Local Interpretable Model-Agnostic Explanations (LIME), to present insights and transparency through visualizations into the model's decision-making process. The visualizations by LIME help understand the specific image section that contributes to the model's decision, which may help in clinical applications. Results: Experimental results show an enhancement in accuracy by 7\% of the fusion model, achieving an accuracy of 97.8\% compared to the individual stand-alone models. The usage of LIME presents the critical regions in the Image leading to cancer detection. Discussion: The enhanced accuracy of Gastric Cancer detection offers high suitability in clinical applications The usage of LIME ensures trustworthiness and reliability in predictions made by the model by presenting the explanations of the decisions, making it useful for medical practitioners. This research contributes to developing an AI-driven, trustworthy cancer detection system that supports clinical decisions and improves patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.